coumarin has been researched along with ucph 101 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Abrahamsen, B; Bunch, L; Gonzalez-Franquesa, A; Huynh, TH; Jensen, AA; Madsen, KK | 1 |
2 other study(ies) available for coumarin and ucph 101
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Design, synthesis and pharmacological characterization of coumarin-based fluorescent analogs of excitatory amino acid transporter subtype 1 selective inhibitors, UCPH-101 and UCPH-102.
Topics: Benzopyrans; Coumarins; Drug Design; Excitatory Amino Acid Transporter 1; Fluorescent Dyes; HEK293 Cells; Humans; Inhibitory Concentration 50; Structure-Activity Relationship | 2012 |